TABLE 5.
Recipient and donor characteristics of mate kidneys, both with DGF, with and without readmission.
| DGF, mate kidney A, readmission (n = 89) | DGF, mate kidney B, no readmission (n = 89) | p-value | |
|---|---|---|---|
| Recipient | |||
| Age (years) | 55.8 ± 12.2 (55.0) | 57.8 ± 11.6 (59.0) | 0.26 |
| Male | 67 (75.3%) | 51 (57.3%) | 0.01 |
| Race | |||
| White | 31 (34.8%) | 38 (42.7%) | 0.75 |
| Black | 15 (16.9%) | 14 (15.7%) | |
| Hispanic | 26 (29.2%) | 22 (24.7%) | |
| Other | 17 (19.1%) | 15 (16.9%) | |
| BMI (kg/m2) | 29.1 ± 5.5 (28.8) | 29.2 ± 5.5 (29.2) | 0.89 |
| Diabetes | 45 (50.6%) | 38 (42.7%) | 0.29 |
| Preemptive | 2 (2.3%) | 6 (6.7%) | 0.15 |
| Length of dialysis | 4.0 ± 2.7 (3.6) | 3.7 ± 1.8 (3.6) | 0.53 |
| Re-transplant | 6 (6.7%) | 4 (4.5%) | 0.52 |
| Donor | |||
| Age (years) | 39.7 ± 14.0 (38.0) | — | |
| Male | 134 (64.1%) | — | |
| Height (cm) | 170.4 ± 13.2 (171.5) | — | |
| KDPI (%) | 53.0 ± 23.7 (51.0) | — | |
| High KDPI | 27 (12.9%) | — | |
| DCD | 62 (29.7%) | — | |
| AKI | 122 (58.4%) | — | |
| Allocation | |||
| Local | 86 (41.1%) | — | |
| Regional | 47 (22.5%) | ||
| National | 76 (36.4%) | ||
| Induction | |||
| Alemtuzumab | 56 (62.9%) | 50 (56.2%) | 0.27 |
| Basiliximab | 27 (83.1%) | 36 (40.4%) | |
| Thymoglobulin | 6 (6.7%) | 3 (3.4%) | |
| CIT (hours) | 21.3 ± 5.8 (21.3) | 21.1 ± 6.0 (21.6) | 0.88 |